Annals of Hepatology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216839, encodeId=8a3b1216839ed, content=请问这本杂志需要每个作者都确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c435424773, createdName=ms8000000835398977, createdTime=Wed May 04 17:12:44 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100958, encodeId=33d11100958fd, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100957, encodeId=28e2110095e45, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-06-11 ms5000001849386227 来自河南省

审稿速度:2.0 | 投稿命中率:75.0
经验分享：提交后两个月左右让大修，2周内提交，2周后接收。

30 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216839, encodeId=8a3b1216839ed, content=请问这本杂志需要每个作者都确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c435424773, createdName=ms8000000835398977, createdTime=Wed May 04 17:12:44 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100958, encodeId=33d11100958fd, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100957, encodeId=28e2110095e45, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-03-26 ms8000000371219882 来自江西省

偏重的研究方向：肝片吸虫病
经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦

39 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216839, encodeId=8a3b1216839ed, content=请问这本杂志需要每个作者都确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c435424773, createdName=ms8000000835398977, createdTime=Wed May 04 17:12:44 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100958, encodeId=33d11100958fd, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100957, encodeId=28e2110095e45, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-09-03 xuanzixue02

修回后，一直under review，这个状态一般持续多久啊？

58 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216839, encodeId=8a3b1216839ed, content=请问这本杂志需要每个作者都确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c435424773, createdName=ms8000000835398977, createdTime=Wed May 04 17:12:44 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100958, encodeId=33d11100958fd, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100957, encodeId=28e2110095e45, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-03-01 ms1000001332961664 来自辽宁省

偏重的研究方向：肝硬化;肝纤维化
经验分享：manuscript submitted有半个月了，正常不？

48 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216839, encodeId=8a3b1216839ed, content=请问这本杂志需要每个作者都确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c435424773, createdName=ms8000000835398977, createdTime=Wed May 04 17:12:44 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100958, encodeId=33d11100958fd, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100957, encodeId=28e2110095e45, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-01-18 国统乃我辈之愿来自海南省

为啥投了10天了，还是submit，没有稿号。

16 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216839, encodeId=8a3b1216839ed, content=请问这本杂志需要每个作者都确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c435424773, createdName=ms8000000835398977, createdTime=Wed May 04 17:12:44 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100958, encodeId=33d11100958fd, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100957, encodeId=28e2110095e45, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-12-16 ms1000000012388850 来自北京

审稿速度:2.0 | 投稿命中率:95.0
经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步

27 0

[GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216839, encodeId=8a3b1216839ed, content=请问这本杂志需要每个作者都确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c435424773, createdName=ms8000000835398977, createdTime=Wed May 04 17:12:44 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100958, encodeId=33d11100958fd, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100957, encodeId=28e2110095e45, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-08-28 Doctor小雷

偏重的研究方向：肝癌
经验分享：试一下这个OA期刊把

52 0

[GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216839, encodeId=8a3b1216839ed, content=请问这本杂志需要每个作者都确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c435424773, createdName=ms8000000835398977, createdTime=Wed May 04 17:12:44 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100958, encodeId=33d11100958fd, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100957, encodeId=28e2110095e45, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-05-04 ms8000000835398977

请问这本杂志需要每个作者都确认吗？

59 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216839, encodeId=8a3b1216839ed, content=请问这本杂志需要每个作者都确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c435424773, createdName=ms8000000835398977, createdTime=Wed May 04 17:12:44 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100958, encodeId=33d11100958fd, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100957, encodeId=28e2110095e45, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-29 Mia

期刊发送邮件中包括哪几个方面的内容？

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142167, encodeId=27de214216ecc, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：提交后两个月左右让大修，2周内提交，2周后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de0d8349111, createdName=ms5000001849386227, createdTime=Sun Jun 11 09:40:46 CST 2023, time=2023-06-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2121929, encodeId=b9402121929a3, content=偏重的研究方向：肝片吸虫病 经验分享：3月9号投稿，到现在还没有更新状态，各位战友这个杂志啥时候能分配编辑哦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=848d8445337, createdName=ms8000000371219882, createdTime=Sun Mar 26 17:36:03 CST 2023, time=2023-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1242980, encodeId=984212429806f, content=修回后，一直under review，这个状态一般持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Sat Sep 03 15:40:49 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117025, encodeId=39d0211e0254c, content=偏重的研究方向：肝硬化;肝纤维化 经验分享：manuscript submitted有半个月了，正常不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26928427487, createdName=ms1000001332961664, createdTime=Wed Mar 01 11:20:38 CST 2023, time=2023-03-01, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2182480, encodeId=f1002182480b5, content=为啥投了10天了，还是submit，没有稿号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jan 18 19:03:22 CST 2024, time=2024-01-18, status=1, ipAttribution=海南省), GetPortalCommentsPageByObjectIdResponse(id=2175308, encodeId=aa7121e530803, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：9-18投，大约6周审稿，返修，再审稿，再返修，12-4接收。但是接收后尚未收到下一步, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8f45549275, createdName=ms1000000012388850, createdTime=Sat Dec 16 18:16:09 CST 2023, time=2023-12-16, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1241472, encodeId=82bc12414e2ce, content=偏重的研究方向：肝癌 经验分享：试一下这个OA期刊把, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Sun Aug 28 10:39:27 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1216839, encodeId=8a3b1216839ed, content=请问这本杂志需要每个作者都确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c435424773, createdName=ms8000000835398977, createdTime=Wed May 04 17:12:44 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100958, encodeId=33d11100958fd, content=期刊发送邮件中包括哪几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100957, encodeId=28e2110095e45, content=期刊给我发了一封信，但我看不懂怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 衣谷

期刊给我发了一封信，但我看不懂怎么办？

61 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务